BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27146666)

  • 1. Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
    Frøyshov HM; Bjørnerem Å; Engstad T; Halvorsen DS
    Aging Clin Exp Res; 2017 Jun; 29(3):379-385. PubMed ID: 27146666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
    Di Napoli M; Papa F;
    Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
    Li YM; Liu XY
    J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.
    Naess H; Nyland H; Idicula T; Waje-Andreassen U
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e435-40. PubMed ID: 23735372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
    ; Kaptoge S; Di Angelantonio E; Lowe G; Pepys MB; Thompson SG; Collins R; Danesh J
    Lancet; 2010 Jan; 375(9709):132-40. PubMed ID: 20031199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).
    Koton S; Tanne D; Green MS; Bornstein NM
    Neuroepidemiology; 2010; 34(2):90-6. PubMed ID: 20016218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
    Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
    Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
    Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Bickel C; Rupprecht HJ; Blankenberg S; Espiniola-Klein C; Schlitt A; Rippin G; Hafner G; Treude R; Othman H; Hofmann KP; Meyer J;
    Am J Cardiol; 2002 Apr; 89(8):901-8. PubMed ID: 11950425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
    Whiteley W; Jackson C; Lewis S; Lowe G; Rumley A; Sandercock P; Wardlaw J; Dennis M; Sudlow C
    Stroke; 2011 Jan; 42(1):10-6. PubMed ID: 21127302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.
    Wang C; Gao L; Zhang ZG; Li YQ; Yang YL; Chang T; Zheng LL; Zhang XY; Man MH; Li LH
    Mol Neurobiol; 2016 Apr; 53(3):1509-1517. PubMed ID: 25650122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.
    Ahmadi-Abhari S; Luben RN; Wareham NJ; Khaw KT
    Eur J Epidemiol; 2013 Jul; 28(7):541-50. PubMed ID: 23821244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
    Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
    Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death.
    Reiche EMV; Gelinksi JR; Alfieri DF; Flauzino T; Lehmann MF; de Araújo MCM; Lozovoy MAB; Simão ANC; de Almeida ERD; Maes M
    Metab Brain Dis; 2019 Jun; 34(3):789-804. PubMed ID: 30875023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
    Wu Z; Huang Z; Jin W; Rimm EB; Lichtenstein AH; Kris-Etherton PM; Wu S; Gao X
    Clin Chem; 2017 Mar; 63(3):663-672. PubMed ID: 28031418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
    Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
    J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population.
    Makita S; Nakamura M; Satoh K; Tanaka F; Onoda T; Kawamura K; Ohsawa M; Tanno K; Itai K; Sakata K; Okayama A; Terayama Y; Yoshida Y; Ogawa A
    Atherosclerosis; 2009 May; 204(1):234-8. PubMed ID: 18790479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.